Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by TechOneon Aug 05, 2020 12:02am
196 Views
Post# 31365012

New Board Member

New Board Member
johnN John Nosenzo
Chief Commercial Officer
Experience

John Nosenzo is the Chief Commercial Officer for Bioventus. He joined the company on February 6, 2017. Prior to joining Bioventus, John worked for six years at Beckman Coulter Diagnostics as its Senior Vice President, Global Customer Operations. Previously, John served as Senior Vice President, Customer Relations Management for Siemens Healthcare where he developed and implemented sales plans for the company’s multi-billion dollar healthcare imaging and healthcare IT commercial organizations.

Prior to that, John served as Vice President, Marketing and Sales at Quest Diagnostics and spent six years with Siemens Healthcare Diagnostics, which was formerly the Bayer Healthcare Diagnostics Division. At Siemens, John served as Vice President of Sales, Medical Testing Systems before being promoted to Senior Vice President, General Manager- Americas.

John began his career in healthcare with Bayer, working there for more than 15 years within the company’s pharmaceutical division, first in various sales roles, and eventually serving as the Vice President of Sales – Generic Products Division, and later Vice President of Marketing and Sales – Specialty Products of the Schein Pharmaceutical Division where Bayer held an equity position.

Education

John received an MBA in marketing and management from Adelphi University and a Bachelor of Science in pharmacy from St. John’s University.

<< Previous
Bullboard Posts
Next >>